We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.03B
AUM Growth
+$589M
Cap. Flow
+$81.4M
Cap. Flow %
1.35%
Top 10 Hldgs %
18.86%
Holding
1,529
New
146
Increased
642
Reduced
570
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Financials 10.31%
3 Industrials 8.91%
4 Healthcare 8.6%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGX
1251
Blackstone Long-Short Credit Income Fund
BGX
$136M
$247K ﹤0.01%
20,041
-41,404
-67% -$496K
IOVA icon
1252
Iovance Biotherapeutics
IOVA
$1.82B
$246K ﹤0.01%
+16,625
New +$194K
PARAP
1253
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$246K ﹤0.01%
17,917
-600
-3% -$9.55K
ESBA icon
1254
Empire State Realty Series ES
ESBA
$1.34B
$246K ﹤0.01%
24,692
EBF icon
1255
Ennis
EBF
$552M
$246K ﹤0.01%
+12,000
New +$245K
FHN icon
1256
First Horizon
FHN
$12.2B
$245K ﹤0.01%
15,940
-237
-1% -$3.4K
ITT icon
1257
ITT
ITT
$17.5B
$245K ﹤0.01%
1,803
QQXT icon
1258
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$155M
$244K ﹤0.01%
2,679
-33,854
-93% -$3M
EQR icon
1259
Equity Residential
EQR
$24.9B
$244K ﹤0.01%
3,862
-9
-0.2% -$548
QCLN icon
1260
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$603M
$244K ﹤0.01%
7,027
-11,637
-62% -$413K
BME icon
1261
BlackRock Health Sciences Trust
BME
$562M
$243K ﹤0.01%
5,855
NDAQ icon
1262
Nasdaq
NDAQ
$52.7B
$243K ﹤0.01%
3,845
-3,277
-46% -$190K
HUSV icon
1263
First Trust Horizon Managed Volatility Domestic ETF
HUSV
$75.9M
$242K ﹤0.01%
6,752
CLB icon
1264
Core Laboratories
CLB
$488M
$241K ﹤0.01%
14,137
+4,000
+39% +$62.9K
SJM icon
1265
J.M. Smucker
SJM
$12.7B
$241K ﹤0.01%
1,913
+57
+3% +$7.22K
BLD
1266
DELISTED
TopBuild
BLD
$241K ﹤0.01%
546
-236
-30% -$92.3K
AFG icon
1267
American Financial Group
AFG
$11.8B
$240K ﹤0.01%
1,760
-205
-10% -$25.5K
BSCR icon
1268
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.59B
$240K ﹤0.01%
12,416
-317
-2% -$6.13K
NPFD icon
1269
Nuveen Variable Rate Preferred & Income Fund
NPFD
$439M
$239K ﹤0.01%
+13,350
New +$230K
DLO icon
1270
dLocal
DLO
$4.44B
$239K ﹤0.01%
16,230
+400
+3% +$6.69K
YUMC icon
1271
Yum China
YUMC
$16.5B
$238K ﹤0.01%
5,982
+248
+4% +$9.79K
PDX
1272
PIMCO Dynamic Income Strategy Fund
PDX
$955M
$238K ﹤0.01%
+11,200
New +$223K
MAA icon
1273
Mid-America Apartment Communities
MAA
$15.4B
$238K ﹤0.01%
1,805
-89
-5% -$11.6K
VLUE icon
1274
iShares MSCI USA Value Factor ETF
VLUE
$9.17B
$237K ﹤0.01%
2,192
+3
+0.1% +$307
BINC icon
1275
BlackRock Flexible Income ETF
BINC
$16.1B
$237K ﹤0.01%
+4,520
New +$236K

Similar funds

Oppenheimer & Co's Q1 2024 Portfolio in Review

As of Q1 2024, Oppenheimer & Co held 1,529 positions worth $6.03B, up 11% from $5.44B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q1 2024 filing shows 146 new, 642 increased, 570 reduced and 93 closed positions. Its largest new stake was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M. The largest sale was NVIDIA, an estimated $8.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q1 2024 buy was State Street SPDR Portfolio Long Term Treasury ETF: 116,262 shares worth $3.25M.
  • Oppenheimer & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $7.26M increase.
  • Oppenheimer & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $8.83M.
  • Oppenheimer & Co fully exited Pacer Developed Markets International Cash Cows 100 ETF in Q1 2024, selling an estimated $2.89M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $6.03B portfolio in Q1 2024.
  • Oppenheimer & Co opened 146 new positions and closed 93 in Q1 2024.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $6.03B.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.